Affiris will hold clinical trials of Alzheimer's vaccine in Europe

04/26/2010 | Google

Affiris said it will soon conduct clinical trials of AD02, a vaccine candidate for Alzheimer's disease, in six European countries. The Austrian biotech firm said the studies will evaluate the efficacy of the vaccine, which was developed with GlaxoSmithKline, and expects to have results by 2012.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC